Older adults undergoing high-risk emergency general surgery spent about one month less at home in the year after surgery compared with those undergoing lower-risk procedures.

Research involving a Rutgers professor sheds new light on the biological basis of schizophrenia by directly measuring synaptic connections in the human brain using specialized positron emission tomography (PET) imaging.

The study, published in Molecular Psychiatry, was led by senior authors Avram Holmes, associate professor of psychiatry at Robert Wood Johnson Medical School and core faculty member of the Center for Advanced Human Brain Imaging Research within the Rutgers Brain Health Institute, and Rajiv Radhakrishnan, associate professor of psychiatry and radiology and biomedical imaging at Yale University. First author Sidhant Chopra, formerly a postdoctoral fellow in the Holmes Lab, is a McKenzie Research Fellow at Orygen, Australia’s Centre of Excellence in Youth Mental Health, and the University of Melbourne in Australia.

A new study shows that a smoking cessation treatment program delivered at community oncology care settings can nearly double quit rates for cancer patients who currently smoke. Investigators from Mass General Brigham Cancer Institute and Memorial Sloan Kettering Cancer Center led a randomized clinical trial for the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN), testing a treatment program that includes virtual therapy and nicotine replacement medications. Results, published in the Journal of Clinical Oncology, show that the intervention was well utilized and nearly doubled the quit rate at 6 months’ post-treatment.